Hebei Changshan Biochemical Pharmaceutical Co., Ltd.

Historical price data

Hebei Changshan Biochemical Pharmaceutical's mission is to be a global leader in the development and supply of high-quality, life-saving anticoagulant therapies. Its core achievement is establishing itself as a vertically integrated powerhouse in the heparin value chain, from sourcing to finished dosage forms, serving consistent global demand. The company's strategy focuses on leveraging its proprietary biochemical processing platform to maintain cost and quality leadership, while expanding its portfolio of low molecular weight heparin (LMWH) products and exploring novel antithrombotic candidates. Its significant market valuation reflects its entrenched position in this essential therapeutic area.

A proprietary, vertically integrated biochemical processing platform for the extraction, purification, depolymerization, and standardization of heparin and low molecular weight heparin (LMWH) active pharmaceutical ingredients (APIs).

Competes primarily with other integrated Chinese heparin giants like Shenzhen Hepalink and Nanjing King-friend. While global pharma firms compete in branded anticoagulants, and generics companies compete in finished drugs, Changshan's deep vertical integration from raw material to API provides a distinct cost and supply chain advantage.